Consequently, top 6 targets, AKT1, interleukin-6 (IL-6), CAT, Tumor necrosis factor (TNF), CASP3, and PTGS2, were predicted to be the key targets of P. lactiflora in the treatment of PD. This evidence concerns the gene TNF and Parkinson disease.